Viewing Study NCT05926232


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-02-19 @ 8:46 AM
Study NCT ID: NCT05926232
Status: AVAILABLE
Last Update Posted: 2023-07-03
First Post: 2023-06-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access for Repotrectinib
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module